Your browser doesn't support javascript.
Navigating the Heart. The Evolution of the AngioVac System in a Single-center Experience.
Tarzia, Vincenzo; Ponzoni, Matteo; Tessari, Chiara; Evangelista, Giuseppe; Zanella, Fabio; Pittarello, Demetrio; Gerosa, Gino.
  • Tarzia V; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy. Electronic address: v.tarzia@gmail.com.
  • Ponzoni M; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
  • Tessari C; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
  • Evangelista G; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
  • Zanella F; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
  • Pittarello D; Anesthesia and Intensive Care Unit, University of Padua, Padua, Italy; From the Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
  • Gerosa G; Cardiac Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, Padua, Italy.
Curr Probl Cardiol ; 48(4): 101543, 2023 Apr.
Article Dans Anglais | MEDLINE | ID: covidwho-2236160
ABSTRACT
We investigated the efficacy, safety, and versatility of the AngioVac (AngioDynamics, Latham, NY) system for the treatment of intravascular and intracardiac masses of different origins. We prospectively enrolled all consecutive patients treated with the AngioVac system between July-2016 and November-2021 at our institution. Three configurations of the device were adopted in 44 patients a venous-venous circuit in 21 cases (47.7%), a venous-arterial ECMO-like configuration in 20 (45.5%), and a venous-arterial-arterial circuit with 2 centrifugal pumps for left-sided cardiac masses in 3 (6.8%). Successful removal of the mass was achieved in 41 patients (93.2%), while in the other cases conversion to full sternotomy was necessary. Intraoperative complications occurred in 3 cases (6.8%), including 1 death, 1 pulmonary embolization, and 1 cardiac perforation. The AngioVac system is a valid, safe, and versatile option for the treatment of intravascular masses also in patients with prohibitive surgical risk.
Sujets)

Texte intégral: Disponible Collection: Bases de données internationales Base de données: MEDLINE Sujet Principal: Thrombose / Thrombose veineuse / Cardiopathies Type d'étude: Étude pronostique Limites du sujet: Humains langue: Anglais Revue: Curr Probl Cardiol Année: 2023 Type de document: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Collection: Bases de données internationales Base de données: MEDLINE Sujet Principal: Thrombose / Thrombose veineuse / Cardiopathies Type d'étude: Étude pronostique Limites du sujet: Humains langue: Anglais Revue: Curr Probl Cardiol Année: 2023 Type de document: Article